All news

Is Insmed (INSM) Still Undervalued Following Its Jefferies Conference Appearance?

Alpha Vantage · Simply Wall St · · AI-summarised by FinFlash

Insmed (INSM) is presenting at the Jefferies Global Healthcare Conference, prompting a re-evaluation of its stock. Despite recent share price volatility with a 25.85% gain over the last month, the year-to-date return is still down 31.59%. Analysts at Simply Wall St believe Insmed is 38% undervalued with a fair value of

Read original source

INSM company analysis

Understand the context

Published information may change. Summaries can contain errors; check the original source. Educational information only, not investment advice.